Home » Topics » Infection, BioWorld Science

Infection, BioWorld Science
RSS

Agouron presents rhinovirus 3C protease inhibitor as promising clinical candidate

May 5, 1997

Antisense oligonucleotides for RSV infection

May 5, 1997

Roche describes TK inhibitors for recurrent HSV infection

May 5, 1997

SKB reveals metallo-beta-lactamase inhibitors

May 5, 1997

Alpharma's Oral Acyclovir Suspension launched in the U.S.

May 2, 1997

SmithKline Beecham launches antiviral cream for treatment of cold sores

May 2, 1997

Trimeris prepares potent peptide inhibitors of viral fusion

April 30, 1997

Dendrimer polyanions with activity against RSV

April 30, 1997

Preclinical results of IL-12 for chronic viral disease

April 30, 1997

Neuraminidase inhibitors highlighted at antiviral conference

April 29, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 15, 2026.
Ethyreal launches to treat the underlying cause of Graves’, TED
BioWorld
Ethyreal Bio Inc. has come out of stealth mode in order to disclose preclinical data for ETHY-001, its monoclonal antibody targeting thyroid stimulating hormone...
Microbiota modulates the antidepressant effects of GLP-1 analogues
BioWorld Science
Liraglutide, a glucagon-like peptide 1 (GLP-1) receptor agonist used in diabetes and obesity, could alleviate depression through a pathway that does not depend on...
EHA 2026: With new lenses, a changing view on pediatric cancers
BioWorld
In the most simplistic view, adult cancers occur because “immature cells are exposed to mutagens, accumulate mutations, and across life ultimately transform into...
Enliven’s phase I CML data Enable phase III with BCR/ABL1 bid
BioWorld
Tolerability is a key factor in the appeal of Enliven Therapeutics Inc.’s ELVN-001 for previously treated chronic myeloid leukemia (CML), which yielded positive...